The outlook of companies tied to the drug's history presents a challenging investment scenario . While the initial success generated substantial gains, generic copies have significantly eroded revenue. https://bookmarkcolumn.com/story21419898/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-speculative-opportunity